2016
DOI: 10.1016/j.clnesp.2016.02.004
View full text |Buy / Rent full text
|
Sign up to set email alerts
|

Abstract: Objectives: Postoperative ileus is a common complication after colorectal resection. Targinact combines oral oxycodone with naloxone and may reduce opiate-induced gut dysfunction after colorectal surgery. We examined the feasibility of a randomised trial of Targinact within the context of an enhanced recovery (ER) perioperative protocol for laparoscopic colorectal resection in an NHS setting. Methods: This was a single-centre open-label phase II feasibility study. Patients were recruited and randomised to rece… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles